ARCHIVES

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

NCI Awards 41.5 Million for DES Study

February 28, 1975

Task Force Urges HHS to Form Committee To Implement Genetic Testing Regulations

November 7, 1997

ASCO Entering Prime Of Life

May 31, 1991

Breast Cancer Plan Issues Its First RFA, Other Initiatives To Be Announced Soon

April 14, 1995

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

December 15, 2000

MIT’s Robert Weinberg Says He Doesn’t Advise Young People To Enter Career In Cancer Research.

April 7, 2006